Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1991-1-28
|
pubmed:abstractText |
Eighteen outpatients with obsessive-compulsive disorder were treated with either buspirone, a partial serotonin agonist, or clomipramine, a serotonin uptake inhibitor, in a double-blind, random-assignment study. Both drugs led to statistically significant and similar improvements in scores on the Yale-Brown Obsessive-Compulsive Rating Scale and other obsessive-compulsive and depression scales. This preliminary result warrants further exploration with a larger sample and other serotonergic agents.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0002-953X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
148
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
127-9
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:1984696-Adult,
pubmed-meshheading:1984696-Ambulatory Care,
pubmed-meshheading:1984696-Buspirone,
pubmed-meshheading:1984696-Clomipramine,
pubmed-meshheading:1984696-Double-Blind Method,
pubmed-meshheading:1984696-Humans,
pubmed-meshheading:1984696-Obsessive-Compulsive Disorder,
pubmed-meshheading:1984696-Psychiatric Status Rating Scales
|
pubmed:year |
1991
|
pubmed:articleTitle |
Controlled comparison of buspirone and clomipramine in obsessive-compulsive disorder.
|
pubmed:affiliation |
Laboratory of Clinical Science, NIMH, NIH, Bethesda, Md.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial
|